JACOBIO PHARMACEUTICALS
Jacobio Pharmaceuticals, founded in 2015 in Beijing China, is a clinical-stage biotech company dedicated to the development of global truly innovative drugs for the unmet needs in China and abroad. The vision and mission of Jacobio have become a global leader to provide revolutionary therapies for serious and life-threatening diseases such as cancer, autoimmune and infectious diseases. Jacobio is founded by seasoned executives from top global and local pharmaceuticals companies who have an asto... unding track record of success and backed by prestigious venture capital firms such as Lilly Asia Ventures and Qiming Capitals. Dr. Yinxiang Wang, the co-founder and chairman of Jacobio, also is one of the founders of Betta Pharmaceuticals, an A-share listed innovative pharmaceutical company, and the national "The Recruitment Program of Global Experts". The most senior management team has over 20 years of drug R&D experience and successfully brought several innovative drugs into the clinical and market stage. Within 3 years, Jacobio has quickly established a compelling drug R&D team of over 100 employees and one-stop capability covering target discovery, med-chemistry, pharmacology, CMC formulation, clinical, and registration. With those, the company has built up a rich pipeline of 8-10 assets with clear competitive advantages and excellent drug properties. JAB-3068, the most advanced program for Jacobio, has focused on a novel target potential for both immunotherapy and target therapy and enter Phase I clinical trial in US and IND approved at China and clinical trials would be initiate at China very soon.
JACOBIO PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2015-01-01
Status:
Active
Contact:
+86 010-56315466
Email Addresses:
[email protected]
Total Funding:
101.55 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Domain Not Resolving Mobile Non Scaleable Content Nginx IPv6 PHP PHP 7 FLoC Opt-Out
Similar Organizations
CANbridge Pharmaceuticals
CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare .
NewBridge Pharmaceuticals
Newbridge Pharmaceuticals is a pharmaceutical and medical device company engaged in developing oncology and supportive care products.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Investors List
AbbVie Biotech Ventures
AbbVie Biotech Ventures investment in Venture Round - Jacobio Pharmaceuticals
Qiming Venture Partners
Qiming Venture Partners investment in Series C - Jacobio Pharmaceuticals
Qiming Venture Partners
Qiming Venture Partners investment in Series C - Jacobio Pharmaceuticals
Hillhouse Capital Group
Hillhouse Capital Group investment in Series C - Jacobio Pharmaceuticals
Prudence Investment Management
Prudence Investment Management investment in Series C - Jacobio Pharmaceuticals
Qiming Venture Partners
Qiming Venture Partners investment in Venture Round - Jacobio Pharmaceuticals
Lilly Asia Ventures
Lilly Asia Ventures investment in Series B - Jacobio Pharmaceuticals
Qiming Venture Partners
Qiming Venture Partners investment in Series B - Jacobio Pharmaceuticals
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-08-31 | HebeCell | Jacobio Pharmaceuticals investment in Series A - HebeCell | 53 M USD |